×

HL7's new AMS is live!   We are working with Fonteva to resolve log in issues. My Account

Section 1h: Cross-paradigm/Domain Analysis Models
Section 2: Clinical and Administrative Domains

HL7 Domain Analysis Model: Specimen, Release 2

DESCRIPTION

This specification is the second release of a Domain Analysis Model for Specimen, documenting the conceptual information requirements for use cases provided by Clinical Genomics, Anatomic Pathology and Public Health Laboratories, the harmonization with the Biomedical Research Integrated Domain Group (BRIDG) model as well as the business needs of the current v2 and v3 specimen models.

 

ALTERNATIVE NAMES

HL7 Domain Analysis Model: Specimen, Release 2 may also go by the following names or acronyms:

"V3 DAM: Specimen, R2",

TARGETS

  • Clinical and Public Health Laboratories
  • Quality Reporting Agencies
  • Standards Development Organizations (SDOs) 
  • EHR, PHR Vendors
  • Health Care IT Vendors
  • Lab Vendors
  • Local and State Departments of Health
  • Healthcare Institutions (hospitals, long term care, home care, mental health)

BENEFITS

  • Creates a unified approach to specimen related attributes across various use cases
  • Enumerates the related data elements applicable to specimen related use cases from different areas of laboratory functions
  • Enables a starting point for implementers / vendors to consider data elements needed to cover different healthcare functions
  • Expanded the National Cancer Institute Life Sciences DAM to include non-living subject’s specimen

RELATED DOCUMENTS

HL7 Domain Analysis Model: Specimen, Release 2

(Download) (1.25 MB)

HL7 Domain Analysis Model: Specimen, Release 1 (View Brief)

(Download) (1.78 MB)

ADDITIONAL DETAILS

This document is used to inform messaging solutions in v2.x as well as creating FHIR resources. It has also been mapped to DICOM elements in order to support Digital Pathology Workflows.

 

TOPIC

  • Laboratory

BALLOT TYPE

  • Informative

STATUS DATE

2019-04-29

RESPONSIBLE WORK GROUP

Orders and Observations

PRODUCT TYPE

  • Domain Analysis Model

STAKEHOLDERS

  • Clinical and Public Health Laboratories
  • EHR, PHR Vendors
  • Health Care IT Vendors
  • Healthcare Institutions
  • Lab Vendors
  • Local and State Departments of Health
  • Quality Reporting Agencies
  • Standards Development Organizations (SDOs)

FAMILY

  • Cross-paradigm

CURRENT STATE

  • Active

REALM

  • Universal